- Filed
- Mar 18, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Feb 28, 2025 | 202.49M sh |
| Current Liabilities | FY 2025 · Jan 31, 2024 | $1.66B |
| Total Liabilities | FY 2025 · Jan 31, 2024 | $1.84B |
| Current Assets | FY 2025 · Jan 31, 2024 | $1.57B |
| Total Assets | FY 2025 · Jan 31, 2024 | $2.97B |
| Shares Diluted | FY 2025 · Jan 31, 2023 | 200.9M sh |
| Stock Repurchased | FY 2025 · Jan 31, 2023 | $63.04M |
| Capex | FY 2025 · Jan 31, 2023 | $77.65M |
| Operating Cash Flow | FY 2025 · Jan 31, 2023 | $506.76M |
| Cash And Equivalents | FY 2025 · Jan 31, 2023 | $721.9M |
| Eps Diluted | FY 2025 · Jan 31, 2023 | −$0.49 |
| Eps Basic | FY 2025 · Jan 31, 2023 | −$0.49 |
| Sga Expense | FY 2025 · Jan 31, 2023 | $316.23M |
| Rd Expense | FY 2025 · Jan 31, 2023 | $480.58M |
| Net Income | FY 2025 · Jan 31, 2023 | −$97.45M |
| Operating Income | FY 2025 · Jan 31, 2023 | −$88.03M |
| Gross Profit | FY 2025 · Jan 31, 2023 | $1.98B |
| Cost Of Revenue | FY 2025 · Jan 31, 2023 | $536.09M |
| Revenue | FY 2025 · Jan 31, 2023 | $2.52B |
| Stockholders Equity | FY 2025 · Jan 31, 2022 | $275.5M |